BR9801397A - Bactéria atenuada viva sequéncia de nucleotídeos vacina processos para proteção de um animal suscetível contra infecção por actinobacillus pleuropneumoniae e para preparação de uma bactéria atenuada viva e de uma vacina e teste diagnóstico - Google Patents
Bactéria atenuada viva sequéncia de nucleotídeos vacina processos para proteção de um animal suscetível contra infecção por actinobacillus pleuropneumoniae e para preparação de uma bactéria atenuada viva e de uma vacina e teste diagnósticoInfo
- Publication number
- BR9801397A BR9801397A BR9801397A BR9801397A BR9801397A BR 9801397 A BR9801397 A BR 9801397A BR 9801397 A BR9801397 A BR 9801397A BR 9801397 A BR9801397 A BR 9801397A BR 9801397 A BR9801397 A BR 9801397A
- Authority
- BR
- Brazil
- Prior art keywords
- live attenuated
- vaccine
- attenuated bacteria
- protect
- nucleotide sequence
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 2
- 230000002238 attenuated effect Effects 0.000 title 2
- 229960005486 vaccine Drugs 0.000 title 2
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000002773 nucleotide Substances 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201032 | 1997-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9801397A true BR9801397A (pt) | 1999-06-01 |
Family
ID=8228185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9801397A BR9801397A (pt) | 1997-04-10 | 1998-04-08 | Bactéria atenuada viva sequéncia de nucleotídeos vacina processos para proteção de um animal suscetível contra infecção por actinobacillus pleuropneumoniae e para preparação de uma bactéria atenuada viva e de uma vacina e teste diagnóstico |
Country Status (12)
Country | Link |
---|---|
US (1) | US6013266A (pt) |
JP (1) | JPH10290695A (pt) |
KR (1) | KR100510906B1 (pt) |
CN (1) | CN1198918C (pt) |
AU (1) | AU743165B2 (pt) |
BR (1) | BR9801397A (pt) |
CA (1) | CA2228719A1 (pt) |
ES (1) | ES2443094T3 (pt) |
HU (1) | HUP9800855A3 (pt) |
NZ (1) | NZ330159A (pt) |
TW (2) | TW593678B (pt) |
ZA (1) | ZA982870B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
GB0228691D0 (en) * | 2002-12-09 | 2003-01-15 | Imp College Innovations Ltd | Bacterial virulence genes |
US20060216302A1 (en) * | 2003-02-28 | 2006-09-28 | Robert Root-Bernstein | Immunological markers |
US8637047B2 (en) * | 2003-10-30 | 2014-01-28 | Boehringer Ingelheim Vetmedica, Inc. | Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
CA2778252A1 (en) * | 2009-11-10 | 2011-05-19 | Boehringer Ingelheim Vetmedica, Inc. | Actinobacillus suis antigens |
ES2416154B1 (es) | 2011-11-09 | 2015-04-01 | Laboratorios Hipra, S.A. | Cepa viva atenuada de Actinobacillus pleuropneumoniae |
KR101491793B1 (ko) | 2013-09-10 | 2015-02-16 | 대한민국 | 신규한 액티노바실러스 플로르뉴모니아 혈청형 12번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물 |
EP3062816B1 (en) | 2013-11-01 | 2020-08-05 | Boehringer Ingelheim Animal Health USA Inc. | Attenuated pasteurella multocida vaccines & methods of making & use thereof |
CN103777018A (zh) * | 2014-01-16 | 2014-05-07 | 江西农业大学 | 猪传染性胸膜肺炎放线杆菌快速诊断试纸条的制备方法 |
GB202011902D0 (en) * | 2020-07-30 | 2020-09-16 | Imperial College Innovations Ltd | Antinobacillus pleuropneumoniae vaccines |
CN112704732B (zh) * | 2020-12-24 | 2022-02-25 | 华中农业大学 | 一种猪传染性胸膜肺炎放线杆菌亚单位疫苗 |
-
1998
- 1998-04-03 ZA ZA982870A patent/ZA982870B/xx unknown
- 1998-04-08 BR BR9801397A patent/BR9801397A/pt not_active Application Discontinuation
- 1998-04-08 NZ NZ330159A patent/NZ330159A/xx unknown
- 1998-04-08 ES ES04077590.0T patent/ES2443094T3/es not_active Expired - Lifetime
- 1998-04-09 US US09/057,570 patent/US6013266A/en not_active Expired - Lifetime
- 1998-04-09 HU HU9800855A patent/HUP9800855A3/hu unknown
- 1998-04-09 CN CNB981098487A patent/CN1198918C/zh not_active Expired - Lifetime
- 1998-04-09 KR KR1019980012518A patent/KR100510906B1/ko not_active IP Right Cessation
- 1998-04-09 CA CA002228719A patent/CA2228719A1/en not_active Abandoned
- 1998-04-09 AU AU60781/98A patent/AU743165B2/en not_active Ceased
- 1998-04-10 JP JP10098877A patent/JPH10290695A/ja active Pending
- 1998-07-28 TW TW087112330A patent/TW593678B/zh not_active IP Right Cessation
- 1998-07-28 TW TW093112492A patent/TWI241407B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU9800855D0 (en) | 1998-07-28 |
JPH10290695A (ja) | 1998-11-04 |
US6013266A (en) | 2000-01-11 |
CN1202523A (zh) | 1998-12-23 |
ES2443094T3 (es) | 2014-02-17 |
CA2228719A1 (en) | 1998-10-10 |
AU6078198A (en) | 1998-10-15 |
KR100510906B1 (ko) | 2006-01-12 |
NZ330159A (en) | 1998-10-28 |
KR19980081220A (ko) | 1998-11-25 |
AU743165B2 (en) | 2002-01-17 |
TW200502384A (en) | 2005-01-16 |
HUP9800855A3 (en) | 2004-03-29 |
HUP9800855A2 (hu) | 1999-03-29 |
TW593678B (en) | 2004-06-21 |
ZA982870B (en) | 1998-10-09 |
CN1198918C (zh) | 2005-04-27 |
TWI241407B (en) | 2005-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9801397A (pt) | Bactéria atenuada viva sequéncia de nucleotídeos vacina processos para proteção de um animal suscetível contra infecção por actinobacillus pleuropneumoniae e para preparação de uma bactéria atenuada viva e de uma vacina e teste diagnóstico | |
IT1298765B1 (it) | Dispositivo diagnostico e di trattamento per denti | |
BR9501521A (pt) | Unidade de esterilização para canetas dentais e outros instrumentos cirúrgicos | |
BR9506138A (pt) | Cacina viva recombinante aviária bem como fórmula de vacina multivalente | |
BR9507502A (pt) | Formulação de tablete processo de tratamento de infecções bacteriais em seres humanos ou em animais processo para preparação de uma formulação de tablete uso de uma formulação de tablete e processo de tratamento de uma infeção bacterial em um paciente humano | |
FI963281A0 (fi) | Ureaasipohjainen rokote ja helicobakteeri-infektion hoito | |
DK0563265T3 (da) | Orale præparater | |
FR2751223B1 (fr) | Formule de vaccin polynucleotidique felin | |
FR09C0037I2 (fr) | Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise | |
PT1042340E (pt) | Oxima de 6-o-alquil-eritromicina b | |
DZ2283A1 (fr) | Composition de vaccin. | |
NO20001439D0 (no) | 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet | |
DE59705642D1 (de) | Sterile Konnektoranordnung, insbesondere zum medizinischen Gebrauch | |
BR9607462A (pt) | Vacina viva em forma de gel | |
DE10075036I1 (de) | Impfstoff und Diagnostikum fuer den Schweine-cholera-virus | |
BR9706133A (pt) | Mycoplasma synoviae atenuado vivo cultura microbiológica vacina para a proteção de aves domésticas processo para sua preparação e uso da cepa mycoplasma synoviae | |
ES2168265T3 (es) | Vacuna viva de salmonella. | |
BR9814958A (pt) | Proteìna de cimento de tecido, composição farmacêutica, uso da proteìna de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido, molécula de ácido nucleico, vetor de expressão ou de clonagem, célula hospedeira, e, animal transgênico | |
DK0894500T3 (da) | Streptococcus equi-vaccine | |
FI970696A (fi) | Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi | |
AU6200399A (en) | Avian pneumovirus vaccine and diagnostic agent | |
BR0007966A (pt) | Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
DE59901002D1 (de) | Verfahren zur Sterilisation | |
EE9700373A (et) | Helicobacter pyloriga seotud nukleiinhapete ja aminohapete järjestused diagnoosimiseks ja raviks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: INTERVET INTERNATIONAL B.V. (NL) Free format text: TRANSFERIDO DE: AKZO NOBEL N.V. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |